Merck Shares Plunge on Vioxx Denial News
605604
WHITEHOUSE STATION, NJ - Shares of Merck &amp; Co. plunged almost 9 percent Monday after a media report said that documents show the pharmaceutical giant hid or denied evidence for years that its blockbuster arthritis drug Vioxx cause heart problems.
336343
Merck posted a $1.63 billion fourth-quarter loss on Wednesday as charges for its Vioxx litigation settlement dragged down results and share prices.
59069
NEW YORK - The stunning news Thursday that Merck &amp; Co. is withdrawing its pain reliever Vioxx from the market because of health risks is the latest in a series of blows to what only a few years ago was the
565132
The blue-chip Dow Jones average fell  on Thursday after drug maker Merck & Co., a member of the Dow,  recalled its widely sold Vioxx painkiller and oil prices  hovered around $50 a barrel.
406135
US stock futures pointed to a slightly lower open on Tuesday as investors take a step back after last week&#39;s three-day rally, with shares of drug maker Merck &amp; Co.
64708
Shares of Merck &amp; Co. plunged nearly 27 percent yesterday, pulling other stocks down with it, after the pharmaceutical giant yanked its Vioxx arthritis drug off the market because of heart safety concerns.
196745
Wall Street stock indexes closed out a dismal third quarter mixed Thursday after Merck &amp; Co. stated it would remove its best-selling Vioxx arthritis drug from the market.
186104
The withdrawal of painkiller Vioxx means Merck &amp; Co. will miss the already diminished expectations of Wall Street analysts for 2005, the drug maker said yesterday.
199304
WHITEHOUSE STATION, NJ - Merck and Co. shares fell more than 10 per cent in trading on the NYSE on Monday amid reports that company documents showed the pharmaceutical firm knew for years about health issues related to its arthritis drug Vioxx.
318860
NEW YORK (CBS.MW) -- Merck (MRK) shares dipped almost 2 percent to $45.16, making it the biggest decliner in the Dow. The selling is related to just surfacing concerns about the safety of its Vioxx arthritis COX-2 inhibitor drug.
628834
Merck & Co Inc. on Thursday pulled its  arthritis drug Vioxx off the market after a study showed it  doubled the risk of heart attack and stroke, a move that sent  its shares plunging and erased $25 billion from its market  value.
298813
Merck &amp; Co.'s decision to pull its widely prescribed drug Vioxx off the shelves yesterday because of a risk of stroke and heart attacks marked a new low for a pharmaceutical company that has suffered a steady decline in both market position and prestige over the last decade.
394034
Merck reported that fourth-quarter profit plunged 58 percent despite higher revenue as the company took charges for revamping costs, an acquisition and legal reserves.
20275
Shares of Merck &amp; Co. plunged more than 7 percent Monday after a media report said that documents show the pharmaceutical giant hid or denied evidence for years that its blockbuster arthritis drug Vioxx cause heart problems.
115343
WHAT a pill Vioxx turned out to be for Merck. Between 50 cents and 60 cents a share were lopped off expected earnings this year after the US pharmaceutical giant gave up defending its painkiller in public
63892
NEW YORK - Investors sent stocks mostly lower Thursday after Merck & Co. said it would be forced to remove one of its best-selling arthritis drugs from the market due to serious health risks...
408847
Merck posted a $1.63 billion fourth-quarter loss on Wednesday as  charges for its Vioxx litigation settlement dragged down results and share prices.